David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics explains whether or not variant cells pre-exist in tumors or if therapy causes these cells to transform. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.